1. Home
  2. SHIM vs CUE Comparison

SHIM vs CUE Comparison

Compare SHIM & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SHIM
  • CUE
  • Stock Information
  • Founded
  • SHIM 1990
  • CUE 2014
  • Country
  • SHIM United States
  • CUE United States
  • Employees
  • SHIM N/A
  • CUE N/A
  • Industry
  • SHIM
  • CUE Biotechnology: Pharmaceutical Preparations
  • Sector
  • SHIM
  • CUE Health Care
  • Exchange
  • SHIM Nasdaq
  • CUE Nasdaq
  • Market Cap
  • SHIM 53.7M
  • CUE 52.8M
  • IPO Year
  • SHIM 2023
  • CUE 2018
  • Fundamental
  • Price
  • SHIM $2.06
  • CUE $0.70
  • Analyst Decision
  • SHIM Hold
  • CUE Strong Buy
  • Analyst Count
  • SHIM 2
  • CUE 3
  • Target Price
  • SHIM $3.00
  • CUE $3.00
  • AVG Volume (30 Days)
  • SHIM 19.9K
  • CUE 318.8K
  • Earning Date
  • SHIM 08-14-2025
  • CUE 08-13-2025
  • Dividend Yield
  • SHIM N/A
  • CUE N/A
  • EPS Growth
  • SHIM N/A
  • CUE N/A
  • EPS
  • SHIM N/A
  • CUE N/A
  • Revenue
  • SHIM $482,303,000.00
  • CUE $7,991,000.00
  • Revenue This Year
  • SHIM $1.12
  • CUE N/A
  • Revenue Next Year
  • SHIM $7.50
  • CUE $23.84
  • P/E Ratio
  • SHIM N/A
  • CUE N/A
  • Revenue Growth
  • SHIM N/A
  • CUE 13.83
  • 52 Week Low
  • SHIM $1.30
  • CUE $0.45
  • 52 Week High
  • SHIM $4.94
  • CUE $1.99
  • Technical
  • Relative Strength Index (RSI)
  • SHIM 60.54
  • CUE 48.28
  • Support Level
  • SHIM $1.96
  • CUE $0.71
  • Resistance Level
  • SHIM $2.10
  • CUE $0.83
  • Average True Range (ATR)
  • SHIM 0.20
  • CUE 0.07
  • MACD
  • SHIM 0.02
  • CUE 0.00
  • Stochastic Oscillator
  • SHIM 68.13
  • CUE 22.22

About SHIM Shimmick Corporation

Shimmick Corp is a provider of water and other critical infrastructure solutions nationwide. It selectively focuses on the following types of infrastructure projects: Water Treatment, Water Resources, and Other Critical Infrastructure. In water treatment projects the company expands, rehabilitates, upgrades, builds and rebuilds water and wastewater treatment infrastructure, including desalination plants. In water resources projects company builds, expands, and improves water storage and conveyance, dams, levees, flood control systems, pump stations, and coastal protection. In Other Critical Infrastructure projects, It builds, retrofits, expands, rehabilitates, operates, and maintains its nation's critical infrastructure, including mass transit, bridges, and military infrastructure.

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

Share on Social Networks: